Form 4 for PHR Phreesia, Inc.
Accepted 2025-04-08 00:00:00 ET · period of report 2020-02-21 · accession 0001127602-25-011830 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2025-04-08 | 2025-04-04 | PHR | Linetsky David | SVP, Life Sciences | A - Grant | — | +536 | 9,260 | +6% | — |
| D | 2025-04-08 | 2020-02-21 | PHR | Linetsky David | SVP, Life Sciences | M - OptEx | $0.73 | +3,413 | 219.2K | +2% | +$2,491 |
| D | 2025-04-08 | 2025-04-04 | PHR | Linetsky David | SVP, Life Sciences | A - Grant | — | +6,432 | 225.7K | +3% | — |
| D | 2025-04-08 | 2020-02-21 | PHR | Linetsky David | SVP, Life Sciences | M - OptEx | $0.00 | -3,413 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-04-04 | A | A | 536 | — | 9,260 | I | — | — | (F3) Represents Restricted Stock Units ("RSUs") that were fully vested as of the grant date. These RSUs represent awards received in lieu of 50% of the Reporting Person's cash bonus earned for the fiscal year ending January 31, 2025 under the Issuer's Senior Executive Cash Incentive Bonus Plan. The Reporting Person elected to convert such portion of his cash bonus into RSUs representing 115% of the earned cash bonus amount. The number of RSUs granted is based on a per share value of $24.31, the closing price of the Issuer's common stock on April 4, 2025. |
| 2 | Common | Common Stock | 2020-02-21 | M | A | 3,413 | $0.73 | 219,250 | D By Spouse | — | — | (F2) The total in Column 5 has been adjusted to correct an overstatement of holdings by 2,298 shares first reflected in a Form 4 filed on May 5, 2021. |
| 3 | Common | Common Stock | 2025-04-04 | A | A | 6,432 | — | 225,682 | D | — | — | (F3) Represents Restricted Stock Units ("RSUs") that were fully vested as of the grant date. These RSUs represent awards received in lieu of 50% of the Reporting Person's cash bonus earned for the fiscal year ending January 31, 2025 under the Issuer's Senior Executive Cash Incentive Bonus Plan. The Reporting Person elected to convert such portion of his cash bonus into RSUs representing 115% of the earned cash bonus amount. The number of RSUs granted is based on a per share value of $24.31, the closing price of the Issuer's common stock on April 4, 2025. (F2) The total in Column 5 has been adjusted to correct an overstatement of holdings by 2,298 shares first reflected in a Form 4 filed on May 5, 2021. |
| 4 | Derivative | Stock Option (Right to Buy) | 2020-02-21 | M | D | 3,413 | $0.00 | 0 | D | $0.73 · — to 2020-02-25 | 3,413 Common Stock | (F4) This option was fully vested and exercisable as of the date of the reported transaction. |